Jasper Therapeutics (JSPR) Other Non-Current Assets (2020 - 2026)
Jasper Therapeutics (JSPR) reported Other Non-Current Assets of $43,000 for Q2 2026, down 89.7% from $417,000 a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Other Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Jasper Therapeutics posted Other Non-Current Assets of $417,000, down 49.1% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $820,000 in FY2024 (-38.9%), $1.34 million in FY2023 (+76.9%), $759,000 in FY2022 (-75.8%) and $3.13 million in FY2021 (+807.2%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets in data going back to Q4 2020.
- Year over year, Other Non-Current Assets gained in 1 of the last seven quarters, with an average decline of 31.5%.
- The high point for year-over-year Other Non-Current Assets in five years was Q4 2021 (growth of 807.2%); the low point was Q2 2026 (a decline of 89.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.97 Bn | 1,099.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 614.97 Bn | 533.50 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 505.56 Bn | 478.67 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 366.86 Bn | 321.23 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 297.80 Bn | 261.79 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.62 Bn | 235.31 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.78 Bn | 191.18 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 189.91 Bn | 164.11 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Jasper Therapeutics | 14.41 Mn | -112.01 Mn | - | 43,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43,000.00 |
| Dec 31, 2025 | 530,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Jun 30, 2025 | 609,000.00 |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 1.76 Mn |
| Sep 30, 2023 | 828,000.00 |
| Jun 30, 2023 | 862,000.00 |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 4.43 Mn |
| Dec 31, 2021 | 4.47 Mn |
| Sep 30, 2021 | 1.85 Mn |
| Dec 31, 2020 | 890,000.00 |
API Access
Jasper Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();